Nature Communications Perspective: moving phage therapy beyond anecdote to clinical reproducibility

A Nature Communications Perspective by Aleksandra Petrović-Fabijan and Stephen T. Abedon argues that phage therapy must move beyond anecdote to clinical reproducibility, and identifies three foundational pillars to be addressed through interdisciplinary collaboration: drug delivery, treatment effectiveness and managing bacterial resistance.